• 重点介绍了重组人血清白蛋白药学上的应用

    And its application in pharmaceutical field was also introduced.

    youdao

  • 但是植物群的一部分叫做地黄属。--使用药学上对待心脏问题

    Yet the plant is part of a group called Digitalis that is used in medicine to treat heart problems.

    youdao

  • 个案包括了一些药学重要议题这些议题课堂也许不会提及只是简单过。

    The cases cover some important topics in pharmacology which are not covered or dealt with only briefly in formal lectures.

    youdao

  • 制剂含有磺酸多沙唑嗪药学可接受聚合物

    The preparation contains doxazosin mesylate and polymer which is acceptable in pharmacy.

    youdao

  • 透露,均发明化合物药学上可接受载体药物成分

    Also disclosed are pharmaceutical compositions comprising a compound of the invention and a pharmaceutically acceptable carrier.

    youdao

  • 药物组合物制成临床或药学可接受剂型优选注射剂口服制剂

    The medicine composition may be prepared into different pharmaceutically acceptable forms, preferably injection and orally taken preparation.

    youdao

  • 药物组合物可以制成各种药学上可接受的剂型,优选注射剂口服制剂

    The medicine composition may be prepared into different pharmaceutically acceptable forms, preferably injection and oral preparation.

    youdao

  • 提取物药学可以接受载体组成药物组合物,可制备多种制剂片剂胶囊、软胶囊、颗粒剂、滴丸、口服液、注射剂

    It and pharmaceutically acceptable carrier may be form medicine composition capable of being prepared into various preparation forms, such as tablet, capsule, granule, etc.

    youdao

  • 发明公开了6-环丙胺基-8-氯嘌呤核苷化合物包括药学可接受及其制备方法应用

    The present invention discloses 6-cyproamino-8-chloropurine nucleoside compound, including pharmaceutically acceptable salt, its preparation method and application.

    youdao

  • 发明使用具体化学式表示的2- 羟基苯甲酸衍生物药学上可接受

    The present invention uses the 2-hydroxybenzoic acid derivative represented by the specific chemical formula or its pharmaceutically acceptable salt.

    youdao

  • 发明涉及右述结构式(I)表示的天氨酸蛋白酶抑制剂药学上可接受

    The present invention relates to aspartic protease inhibitors represented by the following structural formula (I), or a pharmaceutically acceptable salt thereof.

    youdao

  • 制成临床药学可接受任一剂型,优选口服制剂

    The drug can be prepared into any preparation form acceptable for clinic or pharmacy, while oral preparation is preferential.

    youdao

  • 嗪酮类化合物无论是单一还是一个多个其它具有生物活性的化合物结合药学上都是可行的。

    Pyrazinone, whether single or combine with one or more other therapeutic and activated compounds in conjunction are feasible in pharmacy.

    youdao

  • 所公开式(1.0)ERK抑制剂;及其药学可接受溶剂合物。

    Disclosed are the ERK inhibitors of Formula (1.0) : and the pharmaceutically acceptable salts and solvates thereof.

    youdao

  • 它是以阿卡波糖为药用活性成份药学上可接受辅料混合形成药用组合物

    The acarbose is taken as the medical active component, and the acarbose is mixed with a pharmaceutically acceptable auxiliary material to form the drug composition.

    youdao

  • 它是以阿奇霉素主要活性成分药学可接受辅料通过制剂技术而制成口服缓释混悬剂

    The oral sustained-release dry suspension is prepared from the azithromycin serving as the main active ingredient and pharmaceutically acceptable supplementary materials by pharmaceutical technology.

    youdao

  • 发明涉及通式(1化合物药学上可以接受主要提出4”取 代的13-环氮杂内酯类的衍生物

    The invention relates to compounds of a general formula (1) and pharmaceutically acceptable salts, and mainly discloses 4'-substituted 13-cyclo-aza-lactone derivatives.

    youdao

  • 发明提供药学组合物其包括化学式4化合物它们药学可接受盐类溶剂化物

    The present invention also provides pharmaceutical compositions comprising compounds of formula (4), their pharmaceutically acceptable salts and solvates.

    youdao

  • 式表示新型四唑衍生物可被药学接受的具有优异的降低血糖降低血脂活性

    The new tetrazole derivative or its salt acceptable for materia medica possesses of the excellent activeness to reduce the blood sugar and blood lipid.

    youdao

  • 另外,本发明还提供了包含将单链rna病毒药学可容许的承运混合步骤抗癌制备方法

    Furthermore, the present invention provides methods for producing the anticancer agents, which comprise the step of mixing a minus-strand RNA virus with pharmaceutically acceptable carriers.

    youdao

  • 发明涉及一种无糖型提神咽利喉的糖果,所 糖果由所述复方提取物作为主药,药学可接受辅料组成

    The invention still relates to a sugar-free refreshing and throat beneficiary tabletting candy, comprising the compound extraction as the principal agent and medically acceptable accessories.

    youdao

  • 玉红衍生物药学上允许的辅料加工片剂、胶囊剂口服制剂

    The indirubin derivative and pharmaceutically acceptable supplementary material may be prepared into tablet, capsule or other oral preparation.

    youdao

  • 发明提供包含所化合物药学上可接受组合使用这些组合物治疗各种疾病病症疾患方法

    The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

    youdao

  • 气囊可以装有一定量气体发生包括碳酸盐以及药学上可接受有机酸

    The air sac can also be internally filled with a certain amount of gas generant which includes carbonate and pharmaceutically acceptable organic acid.

    youdao

  • 发明提供具有高血糖素受体拮抗剂活性反向激动剂活性新颖i化合物及其药学上可接受晶体。

    The present invention provides for novel compounds of Formula (I) and pharmaceutically acceptable salts and co-crystals thereof which have glucagon receptor antagonist or inverse agonist activity.

    youdao

  • 发明关于氮杂肽类新颖化合物及其药学上可接受

    This invention relates to novel compounds of the Formula Ib: that are azapeptides, and pharmaceutically acceptable salts thereof.

    youdao

  • 药理实验表明此类化合物药学上可接受各种肿瘤细胞增殖具有抑制作用。

    Pharmacological experiment proves that the compound or relative medical acceptable salt can restrain various cancer cell proliferations.

    youdao

  • 药物组合物制成各种药学上可接受的剂型

    The medicine composition may be prepared into different forms.

    youdao

  • 药物组合物制成各种药学上可接受的剂型

    The medicine composition may be prepared into different forms.

    youdao

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定